Author

Hojin Lee

Yale UniversityORCID 0009-0004-3856-6728Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Hojin Lee1 paper · Korea University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Chatchai PhoomakiD· 1 shared Hannah G. LeaiD· 1 shared Joseph N. ContessaiD· 1 shared Lilian KabecheiD· 1 shared Marta BaroiD· 1 shared Megan C. KingiD· 1 shared Nicholas R. AderiD· 1 shared Vanessa M. KelleyiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chatchai PhoomakORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer ResearchPeer-reviewedJan 27, 2026

Loss of JAK1 Function Causes G2/M Cell Cycle Defects Vulnerable to Kif18a Inhibition

Vanessa M. Kelley, Marta Baro, William E. Gasperi…·Joseph N. Contessa

This study identifies JAK1 as a driver of tumor cell radiosensitivity and shows that Kif18a inhibition can counteract therapeutic resistance by exacerbating mitotic stress.

3 citationstop 4%

humanbulk RNA-seq

𝕏 PostBluesky